Pancreatic Ductal Adenocarcinoma

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Qingcai Meng, Miaoyan Wei, Bo Zhang, Xianjun Yu, Si Shi

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 233; DOI: 10.1186/s40425-019-0703-0
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
May Tun Saung, Stephen Muth, Ding Ding, Dwayne L. Thomas, Alex B. Blair, Takahiro Tsujikawa, Lisa Coussens, Elizabeth M. Jaffee, Lei Zheng

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 118; DOI: 10.1186/s40425-018-0435-6
Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy
Hong Jiang, Brett Knolhoff, Yu Zhu, John Herndon, Irina Shapiro, David Weaver, Jonathan Pachter, Andrea Wang-Gillam, David G DeNardo

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P400; DOI: 10.1186/2051-1426-3-S2-P400
Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
Nitya Nair, Ed Lemmens, Amanda Enstrom, Shih-Yu Chen, Serena Chang, Dung Le, Elizabeth M Jaffee, Holden Maecker, Aimee L Murphy, Dirk G Brockstedt, Chan Whiting

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P102; DOI: 10.1186/2051-1426-3-S2-P102
Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer
Thomas Mace, Reena Shakya, Jason Pitarresi, Shannon Loftus, Benjamin Swanson, Gregory Young, Xioling Zhong, Teresa Zimmers, Michael Ostrowski, Thomas Ludwig, Mark Bloomston, Tanios Bekaii-Saab, Gregory Lesinski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P366; DOI: 10.1186/2051-1426-3-S2-P366
Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
Isabel Poschke, Michael Flossdorf, Marta Faryna, Frank Bergmann, Jessica Hassel, Oliver Strobel, Rienk Offringa

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P44; DOI: 10.1186/2051-1426-3-S2-P44
Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
Qingda Meng, Zhenjiang Liu, Markus Maeurer, Elena Rangelova, Aditya Ambati, Thomas Poiret, Lalit Rane, Shanshan Xie, Bartek Jiri, Caroline Verbeke, Oscar Persson, Matthias Löhr, Ralf Segersvärd, Ernest Dodoo

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P35; DOI: 10.1186/2051-1426-3-S2-P35
Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients
Matthew R Farren, Thomas Mace, Susan Geyer, Sameh Mikhail, Christina Wu, Kristen Ciombor, Sanaa Tahiri, Daniel Ahn, Anne Noonan, Miguel Villalona-Calero, Tanios Bekaii-Saab, Gregory Lesinski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P85; DOI: 10.1186/2051-1426-3-S2-P85
Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
Susan Tsai, Laura McOlash, Douglas B Evans, Bryon Johnson, Jill Gershan

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P99; DOI: 10.1186/2051-1426-2-S3-P99
Clinical experience with live-attenuated, double-deleted (LADD) listeria monocytogenes targeting mesothelin-expressing tumors
Dirk G Brockstedt, Dung T Le, Raffit Hassan, Aimee Murphy, John Grous, Thomas W Dubensky, Elizabeth M Jaffee

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P203; DOI: 10.1186/2051-1426-1-S1-P203

Main menu

Pancreatic Ductal Adenocarcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Pancreatic Ductal Adenocarcinoma

Pages